Drug Markets and the State: A Perspective from Political Economy
2013
- 319Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage319
- Downloads263
- Abstract Views56
Thesis / Dissertation Description
The paper introduces a classification scheme for state approaches to regulation of drug markets. The concept of the 'drug regulation state' is developed to include policies and agencies concerned with all drugs, including legal examples such as tobacco, alcohol, and oxycodone. Approaches to regulation are classified broadly as drug war, harm reduction, decriminalization, and legalization. The approaches and rationales used by various state agents, especially in the United States and Europe, are summarized and analyzed. The history of modern pharmacology and drug regulation is expanded with a focus on the American case. The role of industry in state regulation is analyzed. The history of regulation for common drugs of abuse is broken down by class (opioids, cannabis, and stimulants). The paper concludes that while reform of drug war policies is increasingly popular, developing effective new strategies to mitigate drug harms will be difficult and has powerful opponents.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know